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Summary
Introduction: Mollaret’s meningitis is an unusual and under-appreciated syndrome of benign,
recurrent aseptic meningitis. The available literature indicates that the causative agent is herpes
simplex virus type 2 (HSV-2) in themajority of cases andmuch less frequently herpes simplex virus
type 1 (HSV-1).
Case report: We report the case of a 49-year-old Indian female who had four attacks of recurrent
lymphocyticmeningitis (Mollaret’smeningitis) occurringovera7-year period.Thediagnosis of herpes
simplex meningitis was made at the time of the fourth episode by a positive PCR for herpes simplex
virus infection in thecerebrospinal fluid. During the first three episodes, the patientwas treatedwith
anti-tuberculousdrugs andantibiotics forbacterialmeningitis; however for the last episode,once the
diagnosis of herpes simplex meningitis was confirmed, only symptomatic treatment was given. No
long-term suppressive therapy was given and no recurrence has been experienced so far.
Conclusions: Mollaret’s meningitis should be suspected in all cases of recurrent lymphocytic
meningitis. Early diagnosis may prevent prolonged hospital admissions, unnecessary investigations,
and exposure to unnecessary medications, with the associated considerable costs. Treatment with
acyclovir may be beneficial in decreasing the severity and duration of attacks and in preventing
further episodes. [Au?1].
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Mollaret’s meningitis is an unusual and under-appreciated
syndrome of benign, recurrent aseptic meningitis.1 It is char-
acterized by 3—10 episodes of fever and signs of meningeal
irritation lasting between 2 and 5 days, with spontaneous* Corresponding author. Fax: +974 4392273.
E-mail address: mabukhattab@gmail.com (M.A. Khattab).
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doi:10.1016/j.ijid.2009.01.003recovery.1—3 The available literature indicates that the cau-
sative agent is herpes simplex virus type 2 (HSV-2) in the
majority of cases and much less frequently herpes simplex
virus type 1 (HSV-1).3—5 To date, approximately 59 cases
reported of Mollaret’s meningitis have been reported
[Au?2].1—11 Diagnosis is made by the detection of HSV DNA
in cerebrospinal fluid (CSF).4 Although anti-herpes drugs have
been used in some patients, the disease is usually self-limiting
with no neurologic sequelae.1 We report herein a case ofPublished by Elsevier Ltd. All rights reserved.
Mollaret’s meningitis e477Mollaret’smeningitis thatweencountered recentlyand review
the pertinent literature.
Case report
A 49-year-old Indian female was admitted to Hamad General
Hospital in 2001 with a 1-day history of headache, fever and
vomiting associated with neck pain and blurring of vision. On
physical examination she was febrile with a temperature of
38.5 8C and she had neck stiffness and positive Kernig’s sign.
Investigations revealed a normal non-contrast computed
tomographic scan (CT) of the head. Examination of the
CSF was attempted but failed. She was treated as a case
of bacterial meningitis with intravenous ceftriaxone and
ampicillin. Her fever subsided on the next day and she was
discharged home in good condition after 10 days of therapy.
She remained well until May 2004, when she presented
with low-grade fever associated with chills, headache, and
vomiting. Physical examination was only remarkable for fever
of 37.8 8C and neck stiffness. Investigations revealed a nor-
mal non-contrast CT scan of the head, positive purified
protein derivative (PPD) skin test, and negative ELISA test
for HIV (done once). CSF examination revealed: white blood
cell count (WBC) 1070 cells /mm3 (lymphocytes 97%, neu-
trophils 2%, and monocytes 1%), protein 2.62 g/l, and glucose
2.9 mmol/dl. Bacterial, fungal and mycobacterial cultures
were negative. Viral cultures were not done since this is not
available at our hospital. Because of the finding of lymphatic
CSF, the positive PPD, and the patient’s origin shewas treated
empirically with anti-tuberculous drugs (rifampin, isoniazid,
pyrazinamide and ethambutol for 2 months, followed by
rifampin and isoniazid for 7 months).
She remained well until January 2006, when she was
readmitted with fever, headache, and photophobia and
vomiting of 3 days duration. Physical examination was nega-
tive for meningeal signs. A non-contrast CT scan of the head
was normal. CSF examination revealed: WBC 970 cells /mm3
(lymphocytes 97%, neutrophils 1%, and monocytes 2%), pro-
tein 1.25 g/l, and glucose 2.9 mmol/l. Gram stain showed no
organism, and culture and bacterial latex for pneumococci
and meningococci were all negative. Fungal and mycobac-
terial cultures and PCR for Mycobacterium tuberculosis were
all negative. CSF cytology revealed no malignant cells with
abundant mature lymphocytes and no Mollaret’s cells could
be seen on Papanicolaou and Giemsa stains.Table 1 Serial cerebrospinal fluid findings recorded in the four a
Cerebrospinal fluid findings Dat
200
White blood cells/mm3 ND
Neutrophils %
Lymphocytes %
Monocytes %
Erythrocytes/mm3 ND
Protein (g/l) (normal 0.15—0.45) ND
Glucose (mmol/l) (normal 60—80% of blood glucose) ND
Blood glucose (mmol/l) ND
Viral culture ND
ND, not done.Because the patient had received antibiotics prior to CSF
examination she was managed as a partially treated bacterial
meningitis casewith intravenous ceftriaxone and vancomycin.
Her symptoms improved and she was discharged home. She
was readmitted in July 2007with a fever of 1-day duration and
headache. Physical examination was unremarkable except for
fever. Investigations revealed a normal non-contrast CT scan
andmagnetic resonance image(MRI)of theheadwithcontrast.
Lumbar puncture was attempted on admission but failed. She
was treated empirically for possible bacterial meningitis with
intravenous ceftriaxone and vancomycin. A lumbar puncture
was done on day 2 of admission and revealed: WBC 700 cells
(lymphocytes 90%, neutrophils 2%, andmonocytes 8%), protein
0.53 g/l, and glucose 6.9 mmol/l. Table 1 shows the CSF
findings for each of the admissions. Gram stain and culture,
fungal smear and culture, and acid-fast bacillus (AFB) smear
andculturewereall negative. Theanti-nuclear antibody (ANA)
test was negative. The Venereal Disease Research Laboratory
(VDRL) test in CSF was negative. Serologic testing for herpes
was undertaken; serum enzyme immunoassay IgM for HSV-1
was 3.1 (positive at >11.5) and for IgG was 3.5 (positive at
>11.5), and HSV-2 IgM was 4.1 (positive at>11.5) and IgG was
23.2 (positive at >11.5). HSV-1/2 DNA PCR was positive; our
laboratory was unable to make a distinction between the
types. Antibiotics were stopped after the HSV1/2 PCR result.
She felt well and was discharged in good general condition,
with no recurrence through 2008 so far.
Discussion
Recurrent meningitis is a condition characterized by
repeated episodes of acute meningitis followed by periods
during which signs and symptoms are absent and the CSF is
normal. Several conditions have been implicated in causing
recurrent meningitis, including drugs, parameningeal infec-
tions such as sinusitis and mastoiditis, post-traumatic bac-
terial meningitis, Mollaret’s meningitis, systemic lupus
erythematosus, and tumors such as epidermoid cysts and
craniopharyngioma.12
Recurrent benign lymphocytic meningitis was first
described by the French neurologist Pierre Mollaret in
1944, when he reported three cases of recurrent aseptic
meningitis.2 The disease is rare. Up until 2004, approximately
59 cases [Au?2] have been reported in the English language
literature.1—11,13ttacks of meningitis.
e of lumbar puncture
1 21/5/2004 26/1/2006 3/7/2007
1070 970 700
2 1 2
97 97 90
1 2 8
15 120 870
2.62 1.25 0.53
2.9 2.9 6.9
ND 4.8 8.9
ND ND ND
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meningitis characterizedby3—10episodesof feverand signsof
meningeal irritation lasting between 2 and 5 days, with spon-
taneous recovery.1—3HSV-2hasbeen responsible for themajor-
ity of cases, with few cases caused by HSV-1 and Epstein—Barr
virus.3—5 This disease is most commonly seen in young adults,
although the age range of reported cases is 5 to 57 years. There
is a female predominance. In three studies with a total of 41
patients with Mollaret’s meningitis, the female to male ratio
was 1.7:1.8,14,15 Theattacks ofmeningitis occur suddenly,with
the initial presentation being indistinguishable from other
forms of life-threatening meningitis.1—3 This maymake differ-
entiation of Mollaret’s meningitis from other forms very diffi-
cult. The individual episodes vary in intensity and time to
recurrence. Approximately one-half of patients have transient
neurologic manifestations, including seizures, hallucinations,
diplopia, and cranial nerve palsies.16 Lumbar puncture reveals
amixed lymphocytic and polymorphonuclear pleocytosis, with
leukocytes ranging from hundreds to thousands per cubic
millimeter. During the first 24 h of the disease the CSF will
show predominant polymorphonuclear neutrophils and large
cells that have been called endothelial (Mollaret’s) cells. The
protein concentration is only mildly elevated, usually being
less than 100 mg/ml, and the glucose concentration is usually
normal.8 Non-invasive diagnostic testing in recurrent aseptic
meningitis has replaced brain biopsy as the gold standard for
diagnosis.HSVPCR inCSFhas a sensitivity of 95%and specificity
of 100%17,18 and is now considered to be the gold standard for
diagnosis. CSF viral culture is usually negative. The benign
nature of the condition and spontaneous resolution precludes
any definitive recommendation regarding efficacy of any
treatment used. Acyclovir has been used for treatment of
acute episodes and suppression of recurrence, however its
usefulness and efficacy remain unknown.1,16
Our patient fulfilled the criteria for the diagnosis Mollar-
et’s meningitis proposed by Bruyn et al. (Table 2).19 She had a
similar clinical presentation and CSF profile to those cases of
Mollaret’s meningitis reported by others. Diagnosis was
delayed in our patient for almost 6 years and was only made
at the time of the fourth attack. The consequences of this
delay were significant to the patient and included the receipt
of two courses of intravenous antibiotics and anti-tubercu-
lous drugs for 9 months in the third episode. In addition to the
possible side effects from the drugs used in treatment, the
excess costs to the patient and community and the psycho-
logical effects of the diagnosis of bacterial or tuberculous
meningitis were also great. Several factors probably contrib-
uted to the delayed diagnosis, including the unavailability of
the PCR testing at our hospital for the first three attacks, theTable 2 Bruyn’s criteria for the clinical diagnosis of Mollar-
et’s meningitis19
Attacks separated by symptom-free periods of weeks to
months
Spontaneous remission of symptoms and signs
Recurrent episodes of severe headache, meningismus, and
fever
Cerebrospinal fluid pleocytosis with large ‘endothelial’ cells,
neutrophils, and lymphocytes
No causative etiological agent has been identifiedrarity of the condition, and the lack of awareness of the
condition among our physicians. Therefore maintaining a
high index of suspicion and requesting the appropriate inves-
tigation, namely herpes virus DNA by PCR amplification on
CSF, may be extremely useful in unexplained viral meningitis.
This may prevent repeated extensive diagnostic investiga-
tions and allow timely treatment. Although confirmation of
the diagnosis of herpes meningitis was made only at the time
of the fourth episode, we believe that previous episodes were
of the same etiology. It was not possible to confirm whether
HSV-1 or HSV-2 was the cause of recurrent meningitis in our
patient because our laboratory was unable to make the
distinction, and she denied any history of previous genital
herpes; however we believe that HSV-2 was the most likely
cause because of the positive serology for HSV-2 and negative
serology for HSV-1. Since our patient had four episodes of
meningitis over a 6-year period, and the last onewasmild, we
opted not to give acyclovir to treat the acute attack or
prophylaxis to prevent future attacks.
In conclusion, Mollaret’s meningitis should be suspected in
all cases of recurrent lymphocyticmeningitis. Diagnosis can be
madebydetectingHSV-2DNA inCSFbyPCRwith sensitivity and
specificity of 95% and 100%, respectively.17,18 Early diagnosis
may prevent prolonged hospital admissions, unnecessary
investigations, and exposure tounnecessarymedications,with
their associated considerable costs. In all confirmed cases of
HSV-2 Mollaret’s meningitis, counseling on genital herpes and
the possibility of transmission of infection should be a compo-
nent of the treatment. Treatment with acyclovir may be
beneficial in decreasing the severity and duration of attacks
and in preventing further episodes.
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